Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 2, 2013, Pages 165-173

  Saxon, Richard R ^a   Chervu, Arun ^b   Jones, Paul A ^c   Bajwa, Tanvir K ^d   Gable, Dennis R ^e   Soukas, Peter A ^f   Begg, Richard J ^g   Adams, John G ^h   Ansel, Gary M ⁱ   Schneider, Darren B ^j   Eichler, Charles M ^k   Rush, Michael J ^l  

^a North County Radiology Medical Group   (United States)

^b Vascular Surgical Associates   (United States)

^c MERCY HOSPITAL AND MEDICAL CENTER   (United States)

^d ST LUKE S MEDICAL CENTER   (United States)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^f ST ELIZABETH'S MEDICAL CENTER   (United States)

^g Heritage Valley Health System   (United States)

^h Department of Surgery   (United States)

ⁱ RIVERSIDE METHODIST HOSPITAL   (United States)

^j WEILL CORNELL MEDICAL COLLEGE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l HOLY CROSS HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; APPLICATION SITE REACTION; ARTERY BYPASS; ARTERY DIAMETER; ARTERY GRAFT; ARTERY OCCLUSION; ARTICLE; ATHERECTOMY; BLOOD CLOT LYSIS; CLINICAL TRIAL; ECHOGRAPHY; ENDARTERECTOMY; FEMALE; FEMOROPOPLITEAL ARTERY OCCLUSIVE DISEASE; FOLLOW UP; GRAFT PATENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; NITINOL STENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLITEF IMPLANT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; VELOCITY;

AGED; ANTICOAGULANTS; COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; FEMORAL ARTERY; HEPARIN; HUMANS; MALE; PERIPHERAL ARTERIAL DISEASE; POLYTETRAFLUOROETHYLENE; POPLITEAL ARTERY; TREATMENT OUTCOME; UNITED STATES;

EID: 84873161378     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2012.10.004     Document Type: Article

References (31)

1. L Norgren, WR Hiatt, and JA Dormandy TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
2. JR Laird, BT Katzen, D Scheinert RESILIENT Investigators Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276
3. M Schillinger, S Sabeti, and C Loewe Balloon angioplasty versus implantation of a nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888
4. M Schillinger, S Sabeti, and P Dick Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting Circulation 115 2007 2745 2749
5. MD Dake, GM Ansel, MR Jaff Zilver PTX Investigators Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
6. B-N Nguyen, MF Conrad, and JM Guest Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent J Vasc Surg 54 2011 1051 1057
7. H Krankenberg, M Schlüter, and HJ Steinkamp Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST) Circulation 116 2007 285 292
8. P Dick, H Wallner, and S Sabeti Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions Catheter Cardiovasc Interv 74 2009 1090 1095
9. RR Saxon, MD Dake, RL Volgelzang, BT Katzen, and GJ. Becker Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease J Vasc Interv Radiol 19 2008 823 832
10. J Kedora, S Hohmann, W Garrett, C Munschaur, B Theune, and D. Gable Randomized comparison of percutaneous Viabahn stent-grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease J Vasc Surg 45 2007 10 16
11. K McQuade, D Gable, G Pearl, B Theune, and S. Black Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent-graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease J Vasc Surg 52 2010 584 591
12. DR. Gable Role of total endoluminal superficial artery bypass J Cardiovasc Surg (Torino) 52 2011 683 700
13. J Lammer, MD Dake, and J Bleyn Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft Radiology 217 2000 95 104
14. T Jahnke, R Andresen, and S Müller-Hülsbeck Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial J Vasc Interv Radiol 14 2003 41 51
15. PJ Bray, WJ Robson, and AE. Bray Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft J Endovasc Ther 10 2003 619 628
16. M Fischer, C Schwabe, and K-L. Schulte Value of the Hemobahn/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience J Endovasc Ther 13 2006 281 290
17. RR Saxon, JM Coffman, JM Gooding, and DJ. Ponec Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions J Vasc Interv Radiol 18 2007 1341 1349
18. YS Alimi, Z Hakam, and O Hartung Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency? Eur J Vasc Endovasc Surg 35 2008 346 352
19. S Kazemi, A Bangash, and M Djelmami-Hani Prospective, randomized comparison of Viabahn stent-graft versus SilverHawk atherectomy for de novo femoropopliteal occlusive disease Am J Cardiol 98 Suppl 1 2006 10M (abstract)
20. Ansel GM. 1-year interim results from the VIBRANT (Viabahn Versus Bare-Nitinol Stent) study of the Gore Viabahn endoprosthesis. Presented at Vascular Interventional Advances (VIVA) Annual Meeting. October 20-23, 2009; Las Vegas, NV.
21. M Rabellino, T Zander, and S Baldi Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment Catheter Cardiovasc Interv 73 2009 701 705
22. PC Begovac, RC Thomson, JL Fisher, A Hughson, and A. Gällhagen Improvements in GORE-TEX Vascular Graft performance by Carmeda BioActive Surface heparin immobilization Eur J Vasc Endovasc Surg 25 2003 432 437
23. JS Lindholt, B Gottschalksen, and N Johannesen The Scandinavian Propaten trial - 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - a randomised clinical controlled multi-centre trial Eur J Vasc Endovasc Surg 41 2011 668 773
24. RR Rutherford, JD Baker, and C Ernst Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
25. D Sacks, DL Marinelli, LG Martin, and JB Spies Technology Assessment Committee of the SCVIR. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices J Vasc Interv Radiol 8 1997 137 149
26. M Bosiers, K Deloose, and J Callaert Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions J Vasc Surg 54 2011 1042 1050
27. JR Schneider, MJ Verta, MJ Alonzo, D Hahn, NH Patel, and S. Kim Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease Vasc Endovasc Surg 45 2011 391 397
28. MD Dake, D Scheinert, and G Tepe Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study J Endovasc Ther 18 2011 613 623
29. G Tepe, T Zeller, and T Albrecht Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
30. M Werk, S Langner, and B Reinkensmeier Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
31. E Minar, and M. Schillinger Innovative technologies for SFA occlusions: drug coated balloons in SFA lesions J Cardiovasc Surg (Torino) 53 2012 481 486